Friday - September 28, 2018 Protecting patient access to licensed and NICE recommended treatments for wet age-related macular degeneration Following the judicial review judgment on 21 September, the High Court has decided that in certain circumstances it is lawful to offer patients bevacizumab injections for the treatment of wet age-related macular degeneration (wet AMD) in preference to approved licensed treatments, even though bevacizumab is not manufactured or licensed for use in the eye. more
Friday - September 21, 2018 Protecting patient access to licensed and NICE recommended treatments for wet age-related macular degeneration Following a judicial review, the High Court has decided that, in certain circumstances, it is potentially lawful to offer patients bevacizumab injections for the treatment of wet age-related macular degeneration (wet AMD) in preference to approved licensed treatments, even though bevacizumab is not manufactured or licensed for use in the eye. more
Thursday - September 20, 2018 Bayer announces Care4Cattle grant recipients in celebration of advancing cattle well-being Three projects to receive Care4Cattle grants for innovations in advancing the well-being of cattle / Care4Cattle received over 100 entries across 37 countries, with winners selected from Australia, Brazil and the United Kingdom more
Advancing Together: Bayer to Acquire Monsanto The acquisition realizes the joint vision of integrated agricultural offering delivering superior solutions for growers and creates an innovation powerhouse for the next generation of farming. more
